Evidence map›Paper›PMID 34706975›Full record

ArticleNeurology2021

Burden of Chronic and Acute Conditions and Symptoms in People With Epilepsy.

Wyatt P Bensken, Guadalupe Fernandez-Baca Vaca, Barbara C Jobst, Scott M Williams, Kurt C Stange, Martha Sajatovic, Siran M Koroukian

Open access · greenAbstract read
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Increased cardiovascular risk in epilepsy.Frontiers in neurology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wyatt P BenskenFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH. wpb27@case.edu.
Guadalupe Fernandez-Baca VacaFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Barbara C JobstFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Scott M WilliamsFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Kurt C StangeFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Martha SajatovicFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Siran M KoroukianFrom the Department of Population and Quantitative Health Sciences, School of Medicine (W.P.B., S.M.W., K.C.S., S.M.K.), Departments of Neurology (G.F.-B.V., M.S.) and Psychiatry (M.S.), University Hospitals Cleveland Medical Center and School of Medicine, and Center for Community Health Integration, Departments of Family Medicine and Community Health and Sociology, Case Comprehensive Cancer Center (K.C.S.), Case Western Reserve University, Cleveland, OH; and Department of Neurology and Geisel School of Medicine (B.C.J.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Dartmouth–Hitchcock Medical Center · US

Funding

Prevention Research Center for Healthy NeighborhoodsU48DP005030 · DP · CASE WESTERN RESERVE UNIVERSITY · PI BORAWSKI, ELAINE A. · 2014 to 2018
$6.8M
Evaluating and Quantifying the Magnitude and Multilevel Causes of Health Disparities in Understudied Minority People with Epilepsy (EQU-ity)F31MD015681 · NIMHD · CASE WESTERN RESERVE UNIVERSITY · PI BENSKEN, WYATT PETER · 2021 to 2022
$54k
ACL HHS U48DP005030NCCDPHP CDC HHS U48 DP005030NIMHD NIH HHS F31 MD015681
6 · The paper itself

Abstract

BACKGROUND AND

objectivesPeople with epilepsy, one-third of whom in the United States are on Medicaid, experience a wide range of chronic and physical comorbidities that influence their care and outcomes. In this study, we examine the burden and racial/ethnic disparities of chronic and acute conditions, injuries, and symptoms in a large and diverse group of people with epilepsy on Medicaid.

methodsUsing 5 years of Medicaid claims data, we identified adults with epilepsy and used all available claims and diagnoses to identify each person's Clinical Classification Codes groups diagnosed during the study period. Using association rule mining, we identified the top combinations of conditions and stratified these by race/ethnicity to identify potential prevalence disparities. We examined the top combinations of conditions in high utilizers; that is, individuals in the top quartile of hospitalizations and emergency department visits.

resultsAmong 81,963 patients, the most common conditions were anxiety and mood disorders (46.5%), hypertension (36.9%), back problems (35.2%), developmental disorders (31.6%), and headache (29.5%). When examining combinations of conditions, anxiety and mood disorders continued to have an outsized prevalence, appearing in nearly every combination. There were notable disparities in disease burden, with American Indians and Alaskan Natives having a substantially higher prevalence of developmental disorders, while Black individuals had a higher prevalence of hypertension. These disparities persisted to the higher-order combinations that included these conditions. High utilizers had a much higher disease burden, with 75.8% having an anxiety or mood disorder, as well as a higher burden of injuries. DISCUSSION: This study shows a high prevalence of psychiatric and physical conditions and identifies racial and ethnic disparities affecting people with epilepsy. Targeting interventions to consider the comorbidities, race, and ethnicity has potential to improve clinical care and reduce disparities.

Indexed as

EpilepsyEthnicityAdultAnxiety DisordersComorbidityHumansMedicaidUnited States

Identifiers

PMID34706975
PMCPMC8673720
OpenAlexW3208883631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.